Cargando…
527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies
BACKGROUND: Patients receiving B-cell-depleting therapies (BCDT) are at an increased risk for severe COVID-19. Passive antibody therapy (PAT), including COVID-19 convalescent plasma (CCP) and monoclonal antibodies (MAB), is hypothesized to be an effective treatment in this population. However, real-...
Autores principales: | SIMEUNOVIC, G O R D A N A, Sullivan, Liam R, Brooks, Heather, Gentile, Sonia K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677108/ http://dx.doi.org/10.1093/ofid/ofad500.596 |
Ejemplares similares
-
A DESCRIPTIVE, RETROSPECTIVE ANALYSIS OF COVID-19 ANTIBODY THERAPY AND ITS EFFECTS ON MORBIDITY AND MORTALITY IN PATIENTS RECEIVING B-LYMPHOCYTE DEPLETING THERAPIES
por: Simeunovic, G., et al.
Publicado: (2023) -
Don Giovanni KV 527
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1992) -
Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
por: Dittmar, Mark, et al.
Publicado: (2023) -
Antibody-mediated cell depletion therapies in multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022) -
Descriptive epidemiology of morbidity and mortality in Minnesota dairy heifer calves
por: Sivula, N.J, et al.
Publicado: (1996)